当前位置:首页 >财报库 > 报告详情

美国医疗健康公司WellgisticsHealthInc.WGRX美股IPO上市招股说明书S-12025-05-05版英文版163页.pdf

上传人: 白**** 编号:652036 2000-01-01 163页 8.04MB

下载:

1、2025/5/11 23:17sec.gov/Archives/edgar/data/2030763/000164117225008712/forms-1.htmhttps:/www.sec.gov/Archives/edgar/data/2030763/000164117225008712/forms-1.htm1/163S-1 1 forms-1.htm S-1 As filed with the United States Securities and Exchange Commission on May 5,2025.Registration No.333-UNITED STATESS

2、ECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM S-1 REGISTRATION STATEMENTUNDER THE SECURITIES ACT OF 1933 Wellgistics Health,Inc.(Exact name of registrant as specified in its charter.)Delaware 8090 93-3264234(State or other jurisdictionof incorporation or organization)(Primary Standard I

3、ndustrialClassification Number)(IRS EmployerIdentification No.)3000 Bayport DriveSuite 950Tampa,FL 33607844-203-6092(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Brian Norton3000 Bayport DriveSuite 950Tampa,FL 33607844-203-6092(Name,a

4、ddress,including zip code and telephone number,including area code,of agent for service)Copies to:Kate L.BechenLouis D.KernDykema Gossett PLLC111 E.Kilbourn Ave.,Suite 1050Milwaukee,WI 53202(414)488-7300 As soon as practicable after the effective date of this Registration Statement.(Approximate date

5、 of commencement of proposed sale to the public)If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933,other than securities offered only in connection with dividend or interest reinvestment plans

6、,check thefollowing box.If this form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please checkthe following box and list the Securities Act registration statement number of the earlier effective registration statement for thesame offering

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据报告的内容,本文主要介绍了Wellgistics Health公司的业务概况、ELOC购买协议以及股票发行情况。 Wellgistics Health是一家成立于2022年的控股公司,主要业务包括药品和医疗保健服务。公司通过两家全资子公司Wood Sage和Wellgistics, LLC以及两家间接子公司Wellgistics Tech & Hub和Wellgistics Pharmacy开展业务。 2025年4月9日,公司与Hudson Global Ventures, LLC签订了ELOC购买协议,公司有权但无义务指示卖方购买最多5000万美元的ELOC股份。这些股份的购买价格将根据公司普通股的市价确定。 此外,公司还向卖方发行了152,000股承诺股份作为签署ELOC购买协议的承诺费。公司还计划通过股票发行筹集资金,用于一般企业用途,包括运营或研发费用以及未来收购的购买价格。 总体来说,Wellgistics Health通过ELOC购买协议和股票发行,旨在筹集资金以支持其业务发展和扩张。
什么是ELOC购买协议? 出售股东将如何出售股票? 公司如何使用股票销售所得?
客服
商务合作
小程序
服务号
折叠